StockWatch
·

ISHITA DRUGS & INDUSTRIES LTD. Q3 FY25 Results

ISHITADRQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue4.1326.2%
Total Income4.2026.3%
Expenditure3.8826.6%
PBT0.3223.3%
Net Profit0.2422.1%
OPM4.96%0.42pp
NPM5.67%0.19pp
EPS0.8023.1%
View full financials

Informational and educational content only. Not investment advice.